Nirman Agri Genetics Ltd Q4 FY25 Earnings Analysis

- Nirman Agri Genetics targets a revenue growth of 150% to 200% annually for the next 5 years. - Current revenue stands at INR173 crores, with guidance to reach INR220-250 crores in FY25. - Expected revenue: - INR432 crores in two years - INR1,000 crores in the next two years - Approximately INR2,000 crores in five years - No plan to reach INR20,000 crores by 2030 (clarified miscalculation). - Growth driven by expanding market share, increased production capacity from own processing plant, and new initiatives like Krushi Dham physical stores. - Operating margins expected to improve to 14%-15% with full utilization of new processing facility. - Growth will be sustainable and spread throughout the year despite seasonality.

- Revenue growth guidance is strong, targeting 150% to 200% growth annually over the next five years. - The company expects to grow from around INR 200 crores currently to INR 2,000 crores in revenue within five years. - Net profit margins are projected to improve, aiming for 14-15% PAT margins, up from current 10-11%. - Full utilization of the company's own processing plant is expected to contribute to margin expansion in upcoming periods. - Q3 FY25 revenue rose 223% YoY, and net profit increased 114% YoY, signaling operational scalability and strong earnings potential. - No immediate fundraising planned; capital allocation will depend on future situation as the company scales. - Earnings per share (EPS) is expected to benefit from the growth in revenues and margins, reflecting sustainable profitability improvements.

- The company has made a capex of about INR 3.5 crores for their factory. - The factory has a revenue potential of INR 500 crores with an expected PAT margin of around 15%. - No specific future capex plans were explicitly mentioned for new factories or expansions. - For the planned growth to INR 2,000 crores revenue in the next five years, no current fundraising or investment plans are in place; decisions will be made based on the situation at that time. - Krushi Dham physical stores are planned as a strategic initiative, with about 25 stores targeted initially, dependent on certifications and licensing. - The company aims to focus on certifications, licensing, and corporate governance improvements to support future growth.

- Currently, Nirman Agri Genetics Limited has no immediate plans for fundraising through debt or equity. - Decisions on fundraising will be made depending on the situation at the relevant time. - The company is focused on its growth strategy and prefers to take fundraising decisions based on need as they scale. - There is no ongoing fundraising activity announced as of the February 27, 2025 conference call.

- Current order book for Kharif season: INR 150 crores (unexecuted orders as of February 2025). - Current order book for Rabi season: INR 98 crores. - Combined order book (Kharif + Rabi): INR 248 crores approximately. - Order book expected to increase by April 2025. - Company standing on INR 173 crores revenue for 9 months FY25. - Expected to meet guidance of INR 220-250 crores revenue for full FY25. - Strong revenue growth indicating timely execution of order book.